Clinical Trials on Advanced Pancreatic Neuroendocrine Tumor in Switzerland
Total 215 results
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Paul Scherrer Institute (PSI)RecruitingNeuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
University Hospital, Basel, SwitzerlandAnaveon AGRecruiting
-
University Hospital Inselspital, BerneUniversity Hospital, Basel, Switzerland; University of Lausanne Hospitals; University... and other collaboratorsTerminatedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
University Hospital, Basel, SwitzerlandUniversity Hospital, Zürich; University Hospital Freiburg; Krebsforschung Schweiz... and other collaboratorsRecruitingThyroid Cancer, Medullary | Neuroendocrine Tumor of the Lung Grade 1 and 2 | Neuroendocrine Tumor of the Thymus Grade 1 and 2 | Neuroendocrine Tumor GEP Grade 1-3Switzerland
-
Novartis PharmaceuticalsTerminatedPancreatic Neuroendocrine Tumors (pNET)United Kingdom, Spain, Netherlands, Italy, Russian Federation, France, Switzerland, United States
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
University Hospital, Basel, SwitzerlandGMP network of BaselCompletedAdvanced MelanomaSwitzerland
-
PIQUR Therapeutics AGCompletedAdvanced Solid TumorsSwitzerland
-
TOLREMO therapeutics AGRecruitingCancer | Adult Solid Tumor | Advanced Solid Tumor | Adult DiseaseSpain, Switzerland
-
Southern Europe New Drug OrganizationPierre Fabre Laboratories; AgennixUnknown
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Southern Europe New Drug OrganizationNovartisUnknownAdvanced Solid TumorsSwitzerland
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Southern Europe New Drug OrganizationNovartis; Schering-PloughUnknownAdvanced Solid TumorsItaly, Switzerland
-
T3 Pharmaceuticals AGRecruiting
-
University Hospital Inselspital, BerneCompletedMerkel Cell Carcinoma | Malignant MelanomaSwitzerland
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Swiss Group for Clinical Cancer ResearchRecruitingAdvanced Solid TumorsSwitzerland
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
University Hospital, Basel, SwitzerlandSanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer LeagueCompletedMetastatic Pancreatic Cancer | Locally Advanced Pancreatic CancerSwitzerland
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
University Hospital Inselspital, BerneCompletedNeuroendocrine Tumors of the AppendixSwitzerland
-
Felix BeuschleinRadboud University Medical Center; University of Zurich; Ludwig-Maximilians -... and other collaboratorsRecruitingPheochromocytoma | ParagangliomaSwitzerland
-
University Hospital, Basel, SwitzerlandActive, not recruitingNeuroendocrine TumorsSwitzerland
-
Prof. Dr. Silke GillessenTerminated
-
University of Lausanne HospitalsFond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...Suspended
-
University of ZurichCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Swiss Group for Clinical Cancer ResearchImmunophotonics, Inc.RecruitingAdvanced Solid TumorsSwitzerland
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
John O. PriorTerminated
-
Centre Hospitalier Universitaire VaudoisImmutep S.A.S.Terminated
-
Centre Hospitalier Universitaire VaudoisCompletedOcular MelanomaSwitzerland
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
University of ZurichCompleted
-
Debiopharm International SARecruitingAdvanced Solid TumorsSpain, United States, Switzerland
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic MelanomaSwitzerland
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
University Hospital Inselspital, BerneCompleted
-
Markus JoergerRecruiting
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Swiss Group for Clinical Cancer ResearchCompletedMelanoma (Skin)Switzerland
-
Prof. Serge LeyvrazCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
University Hospital Inselspital, BerneUniversity Hospital, Geneva; University Hospital, Basel, Switzerland; University... and other collaboratorsRecruitingNeuroendocrine Tumors | Carcinoid TumorSwitzerland